Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H D King

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
The Journal of Antibiotics|November 1, 1977
Mutalomycin, a new polyether antibiotic taxonomy, fermentation, isolation and characterizationT Fehr, H D King, M Kuhn
The Journal of Antibiotics|April 1, 1986
Clavamycins, new clavam antibiotics from two variants of Streptomyces hygroscopicus. I. Taxonomy of the producing organisms, fermentation, and biological activitiesH D King, J Langhärig, J J Sanglier
Biochemistry|September 28, 1982
Interactions of some novel amide-linked bis(acridines) with deoxyribonucleic acidH D King, W D Wilson, E J Gabbay
The Journal of Antibiotics|November 1, 1975
Septamycin, a polyether antibiotic. Taxonomy, fermentation, isolation and characterizationC Keller-Juslén, H D King, Z L Kis, et al.
The Journal of Antibiotics|September 1, 1978
Noboritomycins A and B, new polyether antibioticsC Keller-Juslén, H D King, M Kuhn, et al.
The Journal of Antibiotics|February 1, 1982
Tetronomycin, a novel polyether of unusual structureC Keller-Juslén, H D King, M Kuhn, et al.
Bioconjugate Chemistry|March 17, 1999
Monoclonal antibody conjugates of doxorubicin prepared with branched linkers: A novel method for increasing the potency of doxorubicin immunoconjugatesH D King, D Yurgaitis, D Willner, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1986
Site-specific covalent modification of monoclonal antibodies: in vitro and in vivo evaluationsJ D Rodwell, V L Alvarez, C Lee, et al.
Bioconjugate Chemistry|November 1, 1993
(6-Maleimidocaproyl)hydrazone of doxorubicin--a new derivative for the preparation of immunoconjugates of doxorubicinD Willner, P A Trail, S J Hofstead, et al.
Cancer Research|January 1, 1997
Effect of linker variation on the stability, potency, and efficacy of carcinoma-reactive BR64-doxorubicin immunoconjugatesP A Trail, D Willner, J Knipe, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
The Journal of Antibiotics|November 1, 1977
Mutalomycin, a new polyether antibiotic taxonomy, fermentation, isolation and characterizationT Fehr, H D King, M Kuhn
The Journal of Antibiotics|April 1, 1986
Clavamycins, new clavam antibiotics from two variants of Streptomyces hygroscopicus. I. Taxonomy of the producing organisms, fermentation, and biological activitiesH D King, J Langhärig, J J Sanglier
Biochemistry|September 28, 1982
Interactions of some novel amide-linked bis(acridines) with deoxyribonucleic acidH D King, W D Wilson, E J Gabbay
The Journal of Antibiotics|November 1, 1975
Septamycin, a polyether antibiotic. Taxonomy, fermentation, isolation and characterizationC Keller-Juslén, H D King, Z L Kis, et al.
The Journal of Antibiotics|September 1, 1978
Noboritomycins A and B, new polyether antibioticsC Keller-Juslén, H D King, M Kuhn, et al.
The Journal of Antibiotics|February 1, 1982
Tetronomycin, a novel polyether of unusual structureC Keller-Juslén, H D King, M Kuhn, et al.
Bioconjugate Chemistry|March 17, 1999
Monoclonal antibody conjugates of doxorubicin prepared with branched linkers: A novel method for increasing the potency of doxorubicin immunoconjugatesH D King, D Yurgaitis, D Willner, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1986
Site-specific covalent modification of monoclonal antibodies: in vitro and in vivo evaluationsJ D Rodwell, V L Alvarez, C Lee, et al.
Bioconjugate Chemistry|November 1, 1993
(6-Maleimidocaproyl)hydrazone of doxorubicin--a new derivative for the preparation of immunoconjugates of doxorubicinD Willner, P A Trail, S J Hofstead, et al.
Cancer Research|January 1, 1997
Effect of linker variation on the stability, potency, and efficacy of carcinoma-reactive BR64-doxorubicin immunoconjugatesP A Trail, D Willner, J Knipe, et al.
Pageof 1